Shim Clinic Logo
Erectile DysfunctionPremature EjaculationAndropause

Testosterone Gel, Singapore - Shim Clinic

Testosterone gel


Latest News

U.S. Jury Orders AbbVie to Pay $3 Mln in AndroGel Retrial U.S. Jury Orders AbbVie to Pay $3 Mln in AndroGel Retrial
Wed, 28 Mar 2018 01:19:01 +0800 | Medscape Medical News Headlines
A U.S. jury ordered AbbVie to pay more than $3 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, though the jury did not find AbbVie strictly liable.Reuters Health Information (Source: Medscape Medical News Headlines)

U.S. jury orders AbbVie to pay $3 million in AndroGel retrial
Tue, 27 Mar 2018 04:36:20 +0800 | Reuters: Health
NEW YORK (Reuters) - A U.S. jury on Monday ordered AbbVie Inc to pay more than $3 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, though the jury did not find AbbVie strictly liable. (Source: Reuters: Health)

AbbVie Wins U.S. Trial in Lawsuit Over AndroGel's Risks AbbVie Wins U.S. Trial in Lawsuit Over AndroGel's Risks
Wed, 31 Jan 2018 21:37:22 +0800 | Medscape Diabetes Headlines
A federal jury in Chicago on Friday found AbbVie Inc not liable in a lawsuit by an Arizona man who claimed he had suffered a pulmonary embolism due to using the company's testosterone replacement medication AndroGel.Reuters Health Information (Source: Medscape Diabetes Headlines)

AbbVie wins U.S. trial in lawsuit over AndroGel's risks
Sat, 27 Jan 2018 09:18:41 +0800 | Reuters: Health
(Reuters) - A federal jury in Chicago on Friday found AbbVie Inc not liable in a lawsuit by an Arizona man who claimed he had suffered a pulmonary embolism due to using the company's testosterone replacement medication AndroGel. (Source: Reuters: Health)

U.S. judge tosses verdict against AbbVie in AndroGel case
Sat, 23 Dec 2017 04:06:21 +0800 | Reuters: Health
(Reuters) - A U.S. judge on Friday overturned a $150 million verdict against AbbVie Inc that was first to result from lawsuits claiming that the company fraudulently misrepresented the risks of its testosterone replacement drug AndroGel. (Source: Reuters: Health)

U.S. judge tosses $150 million verdict against AbbVie in AndroGel case
Sat, 23 Dec 2017 03:29:33 +0800 | Reuters: Health
(Reuters) - A U.S. judge on Friday overturned a $150 million verdict against AbbVie Inc in the first federal court case to go to trial over claims that the company fraudulently misrepresented the risks of its testosterone replacement drug AndroGel. (Source: Reuters: Health)

Testosterone Gel Packets (New - Discontinuation)
Tue, 07 Nov 2017 01:00:00 +0800 | FDA Drug Shortages
Drug Shortage (Source: FDA Drug Shortages)

Second U.S. jury finds AbbVie misrepresented risks of AndroGel
Fri, 06 Oct 2017 05:21:42 +0800 | Reuters: Health
(Reuters) - A U.S. jury on Thursday ordered AbbVie Inc to pay more than $140 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, the plaintiff's lawyer said in a statement. (Source: Reuters: Health)

AbbVie hit with $140 million verdict in AndroGel trial: lawyer
Fri, 06 Oct 2017 04:50:37 +0800 | Reuters: Health
(Reuters) - A U.S. jury on Thursday ordered AbbVie Inc to pay more than $140 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, the plaintiff's lawyer said in an emailed statement. (Source: Reuters: Health)

Dose-Response Effects of T Gel in Medically Castrated Men Dose-Response Effects of T Gel in Medically Castrated Men
Thu, 21 Sep 2017 11:14:34 +0800 | Medscape Today Headlines
A new study examines the treatment effects of variable doses of transdermal testosterone gel among medically castrated men.Clinical Endocrinology (Source: Medscape Today Headlines)


Related Concepts


Private & Confidential Service